“We know that pulmonary rehab is a highly effective treatment for COPD because it improves exercise capacity and symptoms and keeps people out of the hospital,” Anne Holland, PhD, professor of physiotherapy at Alfred Health and La Trobe University in Melbourne, Australia, said in a statement. “But less than 10 percent of all COPD patients in developed countries enter a pulmonary rehab program.”
This stems from a lack of adequate medical reimbursement and programs for COPD treatment, according to Dr. Holland. To test outcomes between center- and home-based programs, a research team created an 8-week protocol for COPD home rehab.
Study participants in this program determined their own level of exercise and had a weekly call with a clinician to review their progress and motivate them to focus on improving. Hospital-based participants performed group exercise and had educational sessions twice a week.
The researchers found that both costs and outcomes for the programs were essentially the same, whether at-home or in-hospital. Neither metric produced a significant difference, but neither group retained their fitness improvements, as was expected based on prior COPD research.
More articles on quality:
Patient infection cases linked to dirty scopes continue to mount
FDA issues safety warning on side effects of popular antibiotics
1 out of 11 organ donors died of a drug overdose
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.